Skip to main content
Log in

Trophic Effects of PACAP on Pancreatic Islets: A Mini-Review

  • Published:
Journal of Molecular Neuroscience Aims and scope Submit manuscript

Abstract

Progressive beta-cell insufficiency in the pancreas is a hallmark of both types I and II diabetes, and agents that protect against beta-cell dysfunction are potential drug targets for diabetes mellitus. Pituitary adenylate cyclase-activating polypeptide (PACAP) is a strong secretagogue of insulin from pancreatic islets and is suggested to be involved in physiological blood glucose homeostasis and the pathology of diabetes. Recent studies in genetically engineered animal models have shown that PACAP stimulates pancreatic functions, especially in cooperation with other regulatory factors including glucose. Furthermore, chronic activation of PACAP signaling regulates pancreatic islet mass in a context-dependent manner. Accumulating in vivo and in vitro evidence suggest that PACAP has trophic effects and regulates both proliferation and cell viability of beta-cells and thereby contributes to protection against diabetes. This review focuses on such trophic actions of PACAP on pancreatic beta-cells and discusses the pathophysiological significance of pancreatic PACAP, with the aim to provide information for future development of treatment for diabetes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1

Similar content being viewed by others

References

  • Ahrén B (2008) Role of pituitary adenylate cyclase-activating polypeptide in the pancreatic endocrine system. Ann NY Acad Sci 1144:28–35

    Article  PubMed  Google Scholar 

  • Borboni P, Porzio O, Pierucci D et al (1999) Molecular and functional characterization of pituitary adenylate cyclase-activating polypeptide (PACAP-38)/vasoactive intestinal polypeptide receptors in pancreatic beta-cells and effects of PACAP-38 on components of the insulin secretory system. Endocrinology 140:5530–5537

    Article  CAS  PubMed  Google Scholar 

  • Broca C, Quoyer J, Costes S et al (2009) beta-Arrestin 1 is required for PAC1 receptor-mediated potentiation of long-lasting ERK1/2 activation by glucose in pancreatic beta-cells. J Biol Chem 284:4332–4342

    Article  CAS  PubMed  Google Scholar 

  • Buscail L, Gourlet P, Cauvin A et al (1990) Presence of highly selective receptors for PACAP (pituitary adenylate cyclase activating peptide) in membranes from the rat pancreatic acinar cell line AR 4-2J. FEBS Lett 262:77–81

    Article  CAS  PubMed  Google Scholar 

  • Eizirik D, Mandrup-Poulsen T (2001) A choice of death–the signal-transduction of immune-mediated beta-cell apoptosis. Diabetologia 44:2115–2133

    Article  CAS  PubMed  Google Scholar 

  • Filipsson K, Ahrén B (1998) Protein kinase A inhibition and PACAP-induced insulin secretion in HIT-T15 cells. Ann NY Acad Sci 865:441–444

    Article  CAS  PubMed  Google Scholar 

  • Filipsson K, Kvist-Reimer M, Ahrén B (2001) The neuropeptide pituitary adenylate cyclase-activating polypeptide and islet function. Diabetes 50:1959–1969

    Article  CAS  PubMed  Google Scholar 

  • Fridolf T, Sundler F, Ahrén B (1992) Pituitary adenylate cyclase-activating polypeptide (PACAP): occurrence in rodent pancreas and effects on insulin and glucagon secretion in the mouse. Cell Tissue Res 269:275–279

    Article  CAS  PubMed  Google Scholar 

  • Green B, Irwin N, Cassidy R, Gault V, Flatt P (2006) Long-term administration of PACAP receptor antagonist, PACAP(6-27), impairs glucose tolerance and insulin sensitivity in obese diabetic ob/ob mice. Peptides 27:2343–2349

    Article  CAS  PubMed  Google Scholar 

  • Hamagami K, Sakurai Y, Shintani N et al (2009) Over-expression of pancreatic pituitary adenylate cyclase-activating polypeptide (PACAP) aggravates cerulein-induced acute pancreatitis in mice. J Pharmacol Sci 110:451–458

    Article  CAS  PubMed  Google Scholar 

  • Han B, Wu J (2009) DcR3 protects islet beta cells from apoptosis through modulating Adcyap1 and Bank1 expression. J Immunol 183:8157–8166

    Article  CAS  PubMed  Google Scholar 

  • Hashimoto H, Shintani N, Tanaka K et al (2001) Altered psychomotor behaviors in mice lacking pituitary adenylate cyclase-activating polypeptide (PACAP). Proc Natl Acad Sci USA 98:13355–13360

    Article  CAS  PubMed  Google Scholar 

  • Inagaki N, Yoshida H, Mizuta M et al (1994) Cloning and functional characterization of a third pituitary adenylate cyclase-activating polypeptide receptor subtype expressed in insulin-secreting cells. Proc Natl Acad Sci USA 91:2679–2683

    Article  CAS  PubMed  Google Scholar 

  • Kashimura J, Shimosegawa T, Kikuchi Y, Koizumi M, Toyota T (1991) The stimulatory effect of PACAP 38 on amylase release in dispersed rat pancreatic acini. Tohoku J Exp Med 164:309–318

    Article  CAS  PubMed  Google Scholar 

  • Kawai K, Ohse C, Watanabe Y, Suzuki S, Yamashita K, Ohashi S (1992) Pituitary adenylate cyclase activating polypeptide stimulates insulin release from the isolated perfused rat pancreas. Life Sci 50:257–261

    Article  CAS  PubMed  Google Scholar 

  • Köves K, Arimura A, Vigh S et al (1993) Immunohistochemical localization of PACAP in the ovine digestive system. Peptides 14:449–455

    Article  PubMed  Google Scholar 

  • Lenzen S, Drinkgern J, Tiedge M (1996) Low antioxidant enzyme gene expression in pancreatic islets compared with various other mouse tissues. Free Radic Biol Med 20:463–466

    Article  CAS  PubMed  Google Scholar 

  • Mathis D, Vence L, Benoist C (2001) beta-Cell death during progression to diabetes. Nature 414:792–798

    Article  CAS  PubMed  Google Scholar 

  • Miyata A, Arimura A, Dahl RR et al (1989) Isolation of a novel 38 residue-hypothalamic polypeptide which stimulates adenylate cyclase in pituitary cells. Biochem Biophys Res Commun 164:567–574

    Article  CAS  PubMed  Google Scholar 

  • Movassat J, Saulnier C, Portha B (1997) Insulin administration enhances growth of the beta-cell mass in streptozotocin-treated newborn rats. Diabetes 46:1445–1452

    Article  CAS  PubMed  Google Scholar 

  • Nakata M, Shintani N, Hashimoto H, Baba A, Yada T (2010) Intra-islet PACAP protects pancreatic beta-cells against glucotoxicity and lipotoxicity. J Mol Neurosci, in press

  • Onoue S, Hanato J, Yamada S (2008) Pituitary adenylate cyclase-activating polypeptide attenuates streptozotocin-induced apoptotic death of RIN-m5F cells through regulation of Bcl-2 family protein mRNA expression. FEBS J 275:5542–5551

    CAS  PubMed  Google Scholar 

  • Portela-Gomes G, Lukinius A, Ljungberg O, Efendic S, Ahrén B, Abdel-Halim S (2003) PACAP is expressed in secretory granules of insulin and glucagon cells in human and rodent pancreas. Evidence for generation of cAMP compartments uncoupled from hormone release in diabetic islets. Regul Pept 113:31–39

    Article  CAS  PubMed  Google Scholar 

  • Rhodes C (2005) Type 2 diabetes-a matter of beta-cell life and death? Science 307:380–384

    Article  CAS  PubMed  Google Scholar 

  • Robertson R, Harmon J (2006) Diabetes, glucose toxicity, and oxidative stress: a case of double jeopardy for the pancreatic islet beta cell. Free Radic Biol Med 41:177–184

    Article  CAS  PubMed  Google Scholar 

  • Sakurai Y, Shintani N, Arimori A et al (2010) Cerulein-induced acute pancreatitis in PACAP knockout mice. J Mol Neurosci, in press

  • Shintani N, Tomimoto S, Hashimoto H et al (2004) Functional roles of the neuropeptide PACAP in brain and pancreas. Life Sci 74:337–343

    Article  Google Scholar 

  • Thomas H, Biden T (2009) Bad news for beta-cell apoptosis. Diabetes 58:1725–1727

    Article  CAS  PubMed  Google Scholar 

  • Tomimoto S, Hashimoto H, Shintani N et al (2004) Overexpression of pituitary adenylate cyclase-activating polypeptide in islets inhibits hyperinsulinemia and islet hyperplasia in agouti yellow mice. J Pharmacol Exp Ther 309:796–803

    Article  CAS  PubMed  Google Scholar 

  • Tomimoto S, Ojika T, Shintani N et al (2008) Markedly reduced white adipose tissue and increased insulin sensitivity in adcyap1-deficient mice. J Pharmacol Sci 107:41–48

    Article  CAS  PubMed  Google Scholar 

  • Tsunekawa S, Miura Y, Yamamoto N et al (2005) Systemic administration of pituitary adenylate cyclase-activating polypeptide maintains beta-cell mass and retards onset of hyperglycaemia in beta-cell-specific calmodulin-overexpressing transgenic mice. Eur J Endocrinol 152:805–811

    Article  CAS  PubMed  Google Scholar 

  • Vaudry D, Falluel-Morel A, Bourgault S et al (2009) Pituitary adenylate cyclase-activating polypeptide and its receptors: 20 years after the discovery. Pharmacol Rev 61:283–357

    Article  CAS  PubMed  Google Scholar 

  • Winzell MS, Ahrén B (2007) Role of VIP and PACAP in islet function. Peptides 28:1805–1813

    Article  CAS  PubMed  Google Scholar 

  • Yada T, Sakurada M, Ihida K et al (1994) Pituitary adenylate cyclase activating polypeptide is an extraordinarily potent intra-pancreatic regulator of insulin secretion from islet beta-cells. J Biol Chem 269:1290–1293

    CAS  PubMed  Google Scholar 

  • Yada T, Sakurada M, Ishihara H et al (1997) Pituitary adenylate cyclase-activating polypeptide (PACAP) is an islet substance serving as an intra-islet amplifier of glucose-induced insulin secretion in rats. J Physiol 505:319–328

    Article  CAS  PubMed  Google Scholar 

  • Yada T, Sakurada M, Filipsson K, Kikuchi M, Ahrén B (2000) Intraperitoneal PACAP administration decreases blood glucose in GK rats, and in normal and high fat diet mice. Ann NY Acad Sci 921:259–263

    Article  CAS  PubMed  Google Scholar 

  • Yamada H, Watanabe M, Yada T (2004) Cytosolic Ca2+ responses to sub-picomolar and nanomolar PACAP in pancreatic β-cells are mediated by VPAC2 and PAC1 receptors. Regul Pept 123:147–153

    Article  CAS  PubMed  Google Scholar 

  • Yamamoto K, Hashimoto H, Tomimoto S et al (2003) Overexpression of PACAP in transgenic mouse pancreatic beta-cells enhances insulin secretion and ameliorates streptozotocin-induced diabetes. Diabetes 52:1155–1162

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

Research was supported in part by Grants-in-Aid for Scientific Research (A) and (B) and for Young Scientists (B) from the Japan Society for the Promotion of Science.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Norihito Shintani.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sakurai, Y., Shintani, N., Hayata, A. et al. Trophic Effects of PACAP on Pancreatic Islets: A Mini-Review. J Mol Neurosci 43, 3–7 (2011). https://doi.org/10.1007/s12031-010-9424-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12031-010-9424-z

Keywords

Navigation